Immunoglobulin responsive chronic pain

Journal of Clinical Immunology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Goebel, Andreas ^a  

^a NONE

Author keywords

Chronic pain; Complex regional pain syndrome; CRPS; Intravenous immunoglobulin; Post polio syndrome

Indexed keywords

IMMUNOGLOBULIN; PLACEBO; CYTOKINE;

ANALGESIA; CHRONIC PAIN; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IMMUNE DYSREGULATION; IMMUNOMODULATION; LOW DRUG DOSE; MEDLINE; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; BIOLOGICAL MODEL; CHRONIC DISEASE; COMPLEX REGIONAL PAIN SYNDROMES; FIBROMYALGIA; GLIA; HYPERALGESIA; MAST CELL; NEURALGIA; PAIN; PAIN RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTERIOR HORN CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECRETION (PROCESS); SENSORY NERVE CELL; SPINAL CORD;

CHRONIC DISEASE; COMPLEX REGIONAL PAIN SYNDROMES; CYTOKINES; FIBROMYALGIA; HUMANS; HYPERALGESIA; IMMUNOGLOBULINS, INTRAVENOUS; MAST CELLS; MODELS, IMMUNOLOGICAL; MODELS, NEUROLOGICAL; NEURALGIA; NEUROGLIA; NOCICEPTORS; PAIN; POSTERIOR HORN CELLS; POSTPOLIOMYELITIS SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSORY RECEPTOR CELLS; SPINAL CORD; PAIN MANAGEMENT;

EID: 77956228181     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9403-8     Document Type: Review

References (44)

1. Merskey B. Classification of chronic pain. Seattle: IASP Press; 1994. p. 212.
2. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000; 9;288(5472):1769-1772
3. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 8;196(4286):129-136
4. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333.
5. Phillips C, Main C, Buck R, Aylward M, Wynne-Jones G, Farr A. Prioritising pain in policy making: the need for a whole systems perspective. Health Policy. 2008;88(2-3):166-175
6. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82(4):981-1011.
7. DeLeo JA, Tanga FY, Tawfik VL. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/ hyperalgesia. Neuroscientist. 2004;10(1):40-52.
8. Sweitzer SM, Hickey WF, Rutkowski MD, Pahl JL, DeLeo JA. Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain. 2002;100(1-2):163-170
9. Colburn RW, Rickman AJ, DeLeo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol. 1999;157(2):289-304.
10. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51(2):240-264
11. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10 (9):895-926.
12. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12(11):1269-1277
13. Uçeyler N, Schäfers M, Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res. 2009;196((1):67-78.
14. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004; 6;361(1-3):184-187
15. Foulkes T, Wood JN. Pain genes. PLoS Genet. 2008;4(7): E1000086.
16. McCabe CS, Haigh RC, Ring EF, Halligan PW, Wall PD, Blake DR. A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford). 2004;42(1):97-101.
17. Moseley GL. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain. 2004;108(1-2):192-198
18. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326-331
19. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijistra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 2002;11(1):47-51.
20. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001; 26;57(12):2179-2184 (Pubitemid 34016448)
21. Fernandes ES, Schmidhuber SM, Brain SD. Sensory-nervederived neuropeptides: possible therapeutic targets. Handb Exp Pharmacol. 2009;(194):393-416.
22. Munnikes RJ, Muis C, Boersma M, Heijmans-Antonissen C, Zijlstra FJ, Huygen FJ. Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm. 2005; 14;2005(6):366-372
23. Wieseler-Frank J, Maier SF, Watkins LR. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun. 2005;19(2):104-111
24. de Mos M, Huygen FJ, Dieleman JP, Koopman JS, Stricker BH, Sturkenboom MC. Medical history and the onset of complex regional pain syndrome (CRPS). Pain. 2008;139(2):458-466
25. de Mos M, Huygen FJ, van der Hoeven-Borgman M, Dieleman JP, Ch Stricker BH, Sturkenboom MC. Outcome of the complex regional pain syndrome. Clin J Pain. 2009;25(7):590-597
26. Goebel A, Vogel H, Caneris O, Bajwa Z, Clover L, Roewer N, et al. Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome. J Neuroimmunol. 2005;162(1-2):184-189
27. Blaes F, Schmitz K, Tschernatsch M, Kaps M, Krasenbrink I, Hempelmann G, et al. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology. 2004;63(9):1734-1736
28. Kohr D, Tschernatsch M, Schmitz K, Singh P, Kaps M, Schäfer KH, et al. Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain. 2009;143(3):246-251
29. Goebel A, Stock M, Deacon R, Sprotte G, Vincent A. Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1. Ann Neurol. 2005;57(3):463-464
30. Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol. 2003;105(6):593-602.
31. Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, et al. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology. 2001;57(6 Suppl 1):67-81.
32. Genevay S, Finckh A, Payer M, Mezin F, Tessitore E, Gabay C, et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine (Phila Pa 1976) 2008;1;33(19):2041-2046
33. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3):693-702.
34. Neu IS. Behandlung der Zoster-Neuralgie mit polyvalenten 7Simmunoglobulinen. Fortschritte der Medizin. 1983;101:31-32
35. Goebel A, Netal S, Schedel R, Sprotte G. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med. 2002;3(2):119-127
36. Goebel A, Baranowski AP, Maurer K, Ghiai A, McCabe C, Ambler G. Intravenous immunoglobulin treatment of complex regional pain syndrome: a randomized, controlled trial. Ann Intern Med. 2010;152(3):152-158
37. Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol. 2007;14(1):60-65
38. Gonzalez H, Sunnerhagen KS, Sjöberg I, Kaponides G, Olsson T, Borg K. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol. 2006;5(6):493-500.
39. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48(2):321-328
40. ClinicalTrials.gov. U.S. National Institutes of Health. http://www. clinicaltrials.gov. Accessed December 18, 2009.
41. Current Controlled Trials. Springer Science + Business Media. http://www.controlled-trials.com. Accessed December 18, 2009.
42. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand. 1982;148((8):653-655
43. Munts AG, van der Plas AA, Ferrari MD, Teepe-Twiss IM, Marinus J, van Hilten JJ. Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome [published online ahead of print Dec. 15, 2009]. Eur J Pain
44. Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008;47(2):208-211